Examining the link between kidney function and biomarkers in pulmonary hypertension
Official title: Association Between Biomarkers and Kidney Function Decline in Patients With Pulmonary Hypertension
Run by University of Giessen · NCT06409624 · Data updated 2026-11-12
This study is trying to see how kidney function and certain markers in urine and blood are related in adults with pulmonary hypertension to improve understanding and care for kidney issues in these patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | University of Giessen Academic / other |
| Locations | 2 sites (Bad Nauheim, Hesse and 1 other locations) |
| Status | Recruiting |
| Started | May 31, 2024 |
| Main results expected | October 2027 |
| Study ends | December 2027 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT06409624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are inpatients aged 18 and older with pulmonary hypertension undergoing right heart catheterization.
✕Probably not a fit
Patients with severe chronic kidney disease (eGFR <20 ml/min/1.73 m2) or those with active tumor disease or other significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the relationship between urinary and plasma biomarkers and changes in estimated glomerular filtration rate (eGFR) in patients with pulmonary hypertension (PH). Given that kidney disease is prevalent in approximately 35% of PH patients and is associated with worse outcomes, understanding the mechanisms connecting heart and kidney function is crucial. The study will involve inpatients aged 18 and older who are undergoing right heart catheterization, without any planned interventions. By identifying potential biomarkers, the research seeks to enhance diagnostic and prognostic capabilities for kidney disease in the context of PH.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and treatment strategies for patients with pulmonary hypertension and concurrent kidney disease.
How similar studies have gone: While the specific approach of linking biomarkers to kidney function in PH is novel, similar studies have shown the importance of biomarkers in understanding disease progression in related conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inpatients aged ≥18 years * Undergoing right heart catheterization (RHC) Exclusion Criteria: * multifactorial or indeterminate PH, for which no single underlying mechanism could be reliably classified * active tumor disease requiring targeted therapy * inflammatory or autoimmune disease with renal involvement requiring systemic immunosuppressive treatment * unexplained kidney function decline, defined as serum creatinine increase ≥0.5 mg/dL from baseline within the prior 7 days before RHC * Chronic kidney disease with eGFR \<20 ml/min/1.73 m2 * non-kidney failure requiring extracorporeal or peritoneal ultrafiltration for diuretic-resistant volume overload * if they had received non-steroidal anti-inflammatory drugs or intravenous contrast within 72 hours before RHC * prediagnosed glomerulonephritis * polycystic kidney disease * postrenal obstruction * single kidney (functional or anatomical) * solid organ transplantation * anticipated life expectancy of \<12 months * likelihood of receiving advanced therapy (mechanical circulatory assist device/lung or cardiac transplant) * pregnancy or possibility of pregnancy in the next 12 months * inability to cooperate with respiratory maneuvers during renal Doppler * refusal to participate * not available for follow-up visits
Where it's running
-
Kerckhoff Klinik Heart and Thorax Center
Bad Nauheim, Hesse, Germany Recruiting -
University Hospital Giessen and Marburg, Campus Giessen, Department of Internal Medicine II
Giessen, Hesse, Germany Recruiting
Study contacts
- Principal investigator: Faeq Husain-Syed, MD — University of Giessen
- Study coordinator: Faeq Husain-Syed, MD
- Email: faeq.husain-syed@innere.med.uni-giessen.de
- Phone: +49 641 985 42378
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiovascular health in children and young adults with chronic conditions
This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Levosimendan to see if it helps the heart after PEA in CTEPH
This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD
This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.